2 Beaten-Down Dividend Stocks to Buy in 2025
Portfolio Pulse from
The article suggests that CVS Health and Johnson & Johnson are currently undervalued dividend stocks that could be good investments for 2025, as they are expected to recover from their current downturns.
January 13, 2025 | 11:30 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CVS Health is identified as a beaten-down dividend stock with potential for recovery by 2025, making it a potential buy for long-term investors.
CVS Health is currently undervalued, but its dividend yield and potential for recovery make it an attractive option for investors looking towards 2025.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Johnson & Johnson is mentioned as a dividend stock that is currently undervalued but expected to recover, making it a potential buy for 2025.
Johnson & Johnson, despite its current downturn, is expected to recover, making it a good dividend stock to consider for future investment.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70